Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Melanoma: Time for adjuvant vemurafenib?

Literature DB >> 29532799

Melanoma: Time for adjuvant vemurafenib?

Diana Romero.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2018 PMID： 29532799 DOI： 10.1038/nrclinonc.2018.39

Source DB: PubMed Journal: Nat Rev Clin Oncol ISSN： 1759-4774 Impact factor: 66.675

Keyword Cloud
References

× No keyword cloud information.

1 in total

1. Adjuvant vemurafenib in resected, BRAF^V600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Authors: Michele Maio; Karl Lewis; Lev Demidov; Mario Mandalà; Igor Bondarenko; Paolo A Ascierto; Christopher Herbert; Andrzej Mackiewicz; Piotr Rutkowski; Alexander Guminski; Grant R Goodman; Brian Simmons; Chenglin Ye; Yibing Yan; Dirk Schadendorf
Journal: Lancet Oncol Date: 2018-02-21 Impact factor: 41.316

1 in total

Melanoma: Time for adjuvant vemurafenib?

1. Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

1. Adjuvant vemurafenib in resected, BRAF^V600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.